KISQALI is indicated in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)negative advanced or metastatic breast cancer. Ribociclib (previously LEE 011) is an experimental drug that is an inhibitor of cyclin D1/CDK4 and CDK6, and is being studied as a treatment for drug-resistant cancers.

Where can I buy Kisqali?

Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its presence PAN India with over 20 years of domain experience.

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand KISQALI (ribociclib) on prescription and Import License in Patient's Name only.

For Kisqali or ribociclib price in India.
Please contact +91 9811747774 or neeraj@indianpharmanetwork.co.in
Kisqali (ribociclib)

Get In Touch

Facilitator under Patient Assistance Programs In India

For Indian Patients, doctors and hospitals KISQALI (ribociclib) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.